Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
M&A activity
confidence 95%
filed 2026-10-23
ReNew Energy announced on October 22, 2026, that it has "signed binding agreements for sale of its controlling shareholding in the digital platform 3E" to private equity firm Hg. This constitutes a material disposition/divestiture transaction involving the sale of a controlling equity stake, with proceeds of approximately US$84 million on an original investment of approximately US$56 million. The transaction is explicitly characterized as "a full exit from the investment" and part of ReNew's "capital recycling strategy," making it a discrete M&A event material to investors' assessment of the company's portfolio and capital allocation.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-10-23
Item 8.01
The disclosure centers on Alaunos' delisting status from Nasdaq. The Company received a delisting notice on October 5, 2026 for non-compliance with the Stockholders' Equity Requirement (minimum $2.5M), timely requested a hearing, but then regained compliance following a private placement on October 14, 2026. Nasdaq confirmed compliance on October 22, 2026, cancelling the delisting hearing and allowing continued listing. This is a material resolution of a delisting risk that directly affects the registrant's continued trading status.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-23
Item 5.02
The filing discloses both departures and appointments of directors and executive officers. Peter Gordon, Marguerite Brogan, and Edward Gellert resigned as directors effective October 23, 2026, while Clark Coffee, Mark Manley, and Alexander Chaloff were appointed as directors on the same date. Additionally, Peter Gordon and Marguerite Brogan resigned as CEO and CFO respectively, with Clark Coffee appointed as CEO and Shane McGrogan appointed as CFO. While both departures and appointments occur, the filing's structure and emphasis center on the new appointments with detailed biographical information for each appointee, making exec_appointment the principal disclosed action. The material leadership transition at a fund manager warrants materiality classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-23
Item 2.02
The Item 2.02 disclosure announces third quarter 2026 unaudited consolidated financial results for Avidia Bancorp, Inc., including net income of $8.6 million ($0.47 per share) compared to prior quarter results. The press release (Exhibit 99.1) provides comprehensive quarterly earnings data, balance sheet metrics, and performance ratios. This is a standard quarterly earnings release material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-10-23
Item 3.03
Bank of America issued 80,000 shares of Series WW Preferred Stock on October 23, 2026, materially modifying shareholder rights by imposing dividend restrictions on common and junior preferred stock if full dividends on the Series WW Preferred Stock are not paid.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-10-23
Item 8.01
Bank of America sold 2,000,000 Depositary Shares representing interests in Series WW Preferred Stock on October 23, 2026, constituting a material capital issuance and distribution of equity securities.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-10-23
Item 5.02
Elizabeth H.Z. Thompson, Ph.D., Executive Vice President and Head of Research and Development, is departing the Company effective October 23, 2026, after informing the Company of her planned retirement on April 27, 2026. While she will provide limited consulting services through December 31, 2026, the principal disclosed action is her departure from her executive officer role. The departure of a senior R&D executive at a pharmaceutical company is material to investors assessing the registrant's research capabilities and leadership continuity.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-10-23
Item 8.01
BDR Pharmaceuticals has filed suit against the FDA in the U.S. District Court for the District of Columbia challenging FDA's grant of 10 years of NCE exclusivity for Phathom's VOQUEZNA product. This is material litigation that directly threatens Phathom's regulatory exclusivity and competitive position; an adverse outcome would permit generic competition earlier than anticipated and materially harm the company's business and financial prospects, as explicitly acknowledged in the forward-looking statements risk factors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-10-23
Item 8.01
Climb Bio announced positive Phase 1 clinical trial data for CLYM116/MIL116 presented at ASN Kidney Week 2026, demonstrating favorable pharmacokinetic and pharmacodynamic results including ~70% Gd-IgA1 reduction, >90% APRIL suppression, and a ~33-day half-life supporting Q12W dosing. The data support advancement to Phase 2 (NAVIGATE-2, currently enrolling) and planned Phase 3 initiation in 2027, representing a material clinical development milestone for the company's lead program in IgA nephropathy.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-10-23
EX-99.1
This press release announces a significant operational and clinical milestone for SciSparc's subsidiary NeuroThera: successful completion of manufacturing and European QP batch release certification for SCI-110, completion of site initiation activities across three clinical centers, and advancement toward patient enrollment in an FDA-approved Phase IIb clinical trial for Tourette Syndrome. While this is a positive development in an ongoing drug development program rather than a discrete financial event, M&A activity, or executive change, it represents material progress in a key clinical program that would affect a reasonable investor's assessment of the company's pipeline advancement and near-term operational trajectory.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-10-23
Item 1.01
IPM entered into a definitive Unit Purchase Agreement to acquire Advanced Technology Distributors' business in a two-stage transaction for total consideration up to $2.7 million (49% at First Closing, remaining 51% at Final Closing), expanding IPM's managed services platform, customer base, and recurring revenue.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-10-23
EX-99.1
The press release announces that Founder Group Limited has regained compliance with Nasdaq's minimum publicly held shares requirement (500,000 shares) under Listing Rule 5550(a)(4), after receiving a non-compliance notice on September 16, 2026. While the announcement is positive (compliance regained), it discloses a material delisting risk event—the prior non-compliance that threatened continued listing—and its resolution. This is material to investors as it directly affects the registrant's ability to maintain its Nasdaq listing.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-10-23
Item 7.01
The filing discloses a quarterly cash dividend declaration of $0.165 per common share, payable November 27, 2026, representing a 6% increase over the prior year dividend. This is a routine but material capital allocation decision that affects shareholder returns and is explicitly announced via press release in Item 7.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-10-23
Onconetix disclosed an additional $500,000 advance to Realbotix under a Grid Promissory Note dated September 11, 2026, bringing total outstanding principal to $3.0 million of a $5.0 million commitment. While this is technically a loan advance rather than a new debt issuance by Onconetix itself, it represents a material financial obligation and capital deployment that would affect investor assessment of the company's liquidity and strategic investments. The filing is marked as soliciting material under Rule 14a-12, suggesting concurrent M&A or governance activity, though the core disclosed event is the debt/loan commitment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-23
The 8-K discloses third quarter 2026 financial results for SB Financial Group, Inc. under Item 2.02 (Results of Operations and Financial Condition). The filing includes a news release reporting GAAP net income of $3.9 million ($0.63 per diluted share), total loans of $1.22 billion, total deposits of $1.38 billion, and other key financial metrics. This is a standard quarterly earnings disclosure material to investors' assessment of the company's financial performance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-23
Item 5.02
Bio Essence Corp's Board of Directors was expanded from three to ten members through a shareholder-approved bylaw amendment effective October 19, 2026, and two new directors, Thea Zhang and Geoff Fellows, were elected and appointed to the Board.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-10-23
The 6-K discloses the appointment of Mr. (Alfred) Tan Choong Hau as Chief Executive Officer, Chairman, and director of ARB IOT Group Limited, effective October 23, 2026. While the filing also mentions the concurrent resignation of the prior CEO/Chairman Mr. Liew Kok Leong, the principal disclosed action is the appointment of a new executive to fill the vacancies created by that departure. The filing provides extensive biographical detail on Mr. Tan's 25+ years of leadership and technology experience, indicating the Board's confidence in his qualifications. This is a material change in senior leadership at the registrant.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 92%
filed 2026-10-23
The 6-K discloses a settlement agreement entered into on October 16, 2026, to resolve a consolidated class action lawsuit (Holland v. 9F Inc., No. 2:21-cv-00948) in which 9F was named as a defendant. The settlement provides full release of all claims and is subject to court approval. This is a material litigation settlement that would affect a reasonable investor's assessment of the company's legal and financial position.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-10-23
The 6-K discloses the closing of an additional $2,500,000 senior convertible promissory note (the "Third Additional Note") issued on October 23, 2026, pursuant to a securities purchase agreement. This represents the creation of a new direct financial obligation convertible into ADSs, with specified covenants, interest rates, and events of default. The issuance of convertible debt is a material capital event affecting the registrant's financial obligations and equity structure.
View raw filing on EDGAR →
6-K
Governance Other
confidence 92%
filed 2026-10-23
EX-99.1
This exhibit is a Notice of Extraordinary General Meeting and proxy form for Australian Oilseeds Holdings Limited scheduled for November 10, 2026. The meeting addresses six proposals, including: (1) an 80-for-1 share consolidation; (2) a share capital reduction and reorganization; (3) a share capital increase; (4) adoption of amended memorandum and articles of association; (5) director authorizations; and (6) meeting adjournment authority. These are material corporate governance and capital structure changes that would affect shareholder interests and the company's authorized share capital framework, warranting classification as a material governance event. While this is a shareholder vote notice rather than vote results, it discloses the substantive proposals being voted on and is material to investors assessing the company's capital structure and governance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-23
Valor Energy entered into a securities purchase agreement on October 19, 2026, to sell 2,145,923 unregistered shares of common stock at $2.33 per share for approximately $5 million in gross proceeds. The offering is conducted under Regulation D exemption with accredited and sophisticated investors, and Item 3.02 explicitly incorporates the disclosure as an unregistered equity sale. This is a classic private placement that dilutes existing shareholders and raises capital.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-10-23
Item 5.02
Ms. Jaclyn Hoffman resigned from her position as Chief Marketing Officer of LQR House Inc., effective immediately on October 20, 2026. The filing explicitly states her departure from all officer, director, and employee positions. This is a clear executive departure that would be material to investors assessing the company's leadership and operational continuity.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-10-23
Item 8.01
Citius Oncology received formal notice from Nasdaq granting an extension through April 19, 2027 to comply with the $1.00 per share bid price requirement under Nasdaq Listing Rule 5550(a)(2). The disclosure explicitly states that if the company fails to regain compliance by that date, Nasdaq will provide written notice that the stock is subject to delisting. This is a classic delisting-risk disclosure under Item 8.01, with a specific compliance deadline and clear consequences for non-compliance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-10-23
Item 5.07
Melar Acquisition Corp. shareholders voted at an extraordinary general meeting on October 22, 2026, to approve the proposed business combination with Everli Global Inc. and all related proposals, with Proposal 1 (the business combination) passing with 9,425,113 votes for and 23,978 against, clearing a critical closing condition for the SPAC merger.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-10-23
WEBUY GLOBAL LTD consummated a share subscription on October 22, 2026, issuing 138,370 Class B ordinary shares to Bin Xue at US$0.68 per share. This issuance represents approximately 14.7% of aggregate voting power and increases Bin Xue's total beneficial ownership to 47.4% of voting power. This is a material dilutive equity issuance that would affect a reasonable investor's assessment of ownership structure and voting control.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-23
Item 1.01
House of Doge entered into a binding letter of intent to acquire McQueen Labs' tokenization platform and microlending business for approximately $15 million in stock, convertible preferred shares, and promissory notes, plus contingent consideration. This represents a material strategic expansion into tokenized alternative investments and real-world assets.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-10-23
Item 1.02
House of Doge terminated its material trademark license agreement with the Dogecoin Foundation effective October 19, 2026, eliminating all licenses, exclusivity rights, and board representation, and requiring the company to cease use of licensed marks and change its corporate name by December 31, 2026. The termination is part of a broader strategic restructuring involving contribution of assets to Dogecoin Labs.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-10-23
Item 5.02
CEO Marco Margiotta and CFO Charles Park both resigned effective October 22, 2026, representing the departure of the two most senior officers. Director Tim Stebbing also resigned to join Dogecoin Labs. Curtis Hopkins was appointed as Interim CEO and CFO.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 95%
filed 2026-10-23
This Form 6-K furnishes DDC Enterprise Limited's unaudited interim financial results for the six months ended June 30, 2026, together with management's discussion and analysis. The filing explicitly states "This report on Form 6-K includes the Company's unaudited financial results for the six months ended June 30, 2026" and presents consolidated financial statements and MD&A for that interim period. This is a periodic interim financial report (the foreign-issuer equivalent of a 10-Q), not a discrete event or earnings press release.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 85%
filed 2026-10-23
EX-99.1
The exhibit announces a 10-for-1 forward share split approved by the board on September 28, 2026, effective October 26, 2026. While technically a subdivision of shares rather than a traditional dividend, a share split is a form of capital distribution that affects all shareholders' holdings proportionately and is commonly classified under dividend_distribution in SEC taxonomy. The split is material as it affects share structure, trading mechanics, and investor accessibility, and would inform a reasonable investor's assessment of the company's capital strategy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-10-23
Item 1.01
XCF Global entered into a definitive Asset Purchase and Sale Agreement on October 20, 2026, to acquire a sustainable aviation fuel production facility in Paramount, California through subsidiary New Rise Renewables Paramount, LLC, for $10 million cash at closing plus $50 million deferred payment, adding approximately 50 million annual gallons of production capacity with management targets of $600 million in gross product sales and $40 million in EBITDA post-restart.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-10-23
Ribbon Acquisition Corp. disclosed a $125,000 extension payment deposited into its trust account on October 23, 2026, enabling a one-month extension of its business combination deadline from October 15 to November 15, 2026. This is a material event for a SPAC (special purpose acquisition company) as it directly affects the timeline for completing its initial business combination and the potential return of capital to public shareholders if no combination is consummated by the extended deadline. While this is clearly a material corporate event, it does not fit neatly into the standard taxonomy categories—it is neither a completed M&A transaction, a going-concern issue, nor a routine governance matter, making `other_material` the most appropriate classification.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-10-23
EX-99.1
The exhibit discloses a tender offer launched by Inversiones Aspi S.A. for the shares of Cementos Pacasmayo S.A.A., with formal notice published in Peru's Official Gazette and major newspaper. This constitutes a material acquisition or change-of-control activity requiring disclosure under the Peruvian securities regulations cited (SMV Resolution No. 005-2014-SMV/01), and would materially affect a reasonable investor's assessment of the registrant's ownership and control.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-10-23
Item 5.02
Walter T. Beach resigned as a board member effective immediately on October 20, 2026. The disclosure centers on the departure itself, with explicit confirmation that the resignation was not due to disagreement with the Company. This is a straightforward director departure under Item 5.02, material to investors as board composition changes affect governance and oversight.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-10-23
The 6-K discloses an Exchange Agreement (October 22, 2026) whereby the Company exchanged a $10,000 partitioned note for 24,509 ordinary shares at $0.408 per share, issued under Section 3(a)(9) exemption. Although characterized as a conversion under the existing Note rather than a standalone dilutive issuance, the exchange results in new equity issuance to an existing investor and represents a material capital event affecting share count and ownership structure.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-10-23
EX-99.1
This disclosure concerns a Tender Offer by Inversiones Aspi S.A. for voting shares of Cementos Pacasmayo S.A.A., a material acquisition activity. The exhibit reports that a valuation firm (MSRA S.A.C.) has responded to SMV regulatory comments on the minimum price determination for the tender offer, confirming the valuation stands without modification. This is a key procedural step in a material change-of-control transaction that would materially affect investors' assessment of the company.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-23
Item 1.01
Treasure Global's subsidiary Tadaa entered into a material software development agreement with Techcom Vintage to build a Government Smart Fertilizer Traceability & AI Agriculture Intelligence Platform for RM8,000,000. This is a significant operational and strategic contract involving multi-phase development, government subsidy program support, and substantial fixed fees, but it does not constitute a merger, acquisition, disposition, or change of control (ma_activity), nor does it fit other specific event categories. The agreement is material to investors as it represents a major business initiative and capital commitment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-10-23
Item 1.01
RMX Industries entered into a Securities Purchase Agreement on October 21, 2026, issuing a 12% promissory note with principal of $295,550 (net proceeds $257,000) and potential additional tranches up to $1,100,000, creating a new direct financial obligation with maturity on October 15, 2027.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-23
Item 3.02
RMX Industries completed an unregistered sale of equity securities to Vanquish under a Purchase Agreement, exempt from Securities Act registration under Section 4(a)(2) and Regulation D Rule 506(b), representing a private placement to an accredited investor.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-23
Item 3.02
Item 3.02 discloses the issuance of 5,332,617 restricted shares of common stock to Mandragola Ltd. upon cashless exercise of warrants issued in connection with the DFSL acquisition. The shares were issued in reliance on Section 4(a)(2) of the Securities Act and are restricted securities under Rule 144, meeting the definition of an unregistered equity issuance. This represents a material dilutive event affecting the capital structure and ownership percentages of existing shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-10-23
Item 5.07
This is a clear disclosure of shareholder vote results from a special meeting held on October 23, 2026, presenting final voting tallies on four proposals: approval of reverse stock splits (1:2 to 1:25 ratio), approval of a 20% issuance under Nasdaq Rule 5635(d), amendment to the 2020 Stock Incentive Plan, and adjournment authority. All four proposals passed with overwhelming majorities. The reverse split and dilutive issuance approvals are material to investors' assessment of capital structure and ownership dilution risk.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-10-23
The 6-K discloses an amendment to an existing At-The-Market (ATM) offering agreement with H.C. Wainwright, decreasing the maximum aggregate offering price to $2,006,769 for sale of American Depositary Shares representing ordinary shares. This constitutes a dilutive equity issuance under a registered shelf offering, material to investors assessing capital structure and shareholder dilution risk.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-10-23
This is Banco Bradesco's third-quarter 2026 financial report, containing consolidated financial statements, balance sheet, income statement, and detailed managerial analysis of results. The document is titled "Economic and Financial Analysis Report 3Q26" and includes audited consolidated financial statements with comparative periods (2Q26, 3Q25, 9M26, 9M25), making it a periodic quarterly financial report rather than a discrete earnings event. The filing date of October 23, 2026 aligns with typical quarterly reporting cadence for a foreign private issuer.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-10-23
This is a quarterly financial report for Banco Bradesco for the third quarter of 2026 (3Q26). The document contains detailed financial statements, balance sheet data, income statement analysis, loan portfolio metrics, funding sources, and key performance indicators for the quarter. The header identifies it as a "Managerial Analysis of Results Bradesco | Economic and Financial Analysis Report 3Q26 Press Release," and the body presents consolidated recurring net income (R$7.1 bn), total revenue (R$38.0 bn), and comprehensive quarterly performance metrics. This is the periodic financial report itself, not a discrete earnings announcement event, and should be classified as a periodic quarterly report for deferred processing.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-10-23
EX-99.1
Sigma Lithium extended the maturity of its US$100 million senior secured debt facility with Synergy Capital by six months, from December 2026 to June 2027. While technically an amendment to existing debt rather than a new issuance, the extension materially affects the company's direct financial obligations and debt profile by deferring a significant repayment obligation. The filing emphasizes this extends "93% of its debt profile to June 2027," enhancing financial flexibility—a material capital structure event for a company that has been ramping up production post-restart.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-10-23
Eric Young, Chief Technology Officer of Nu Holdings Ltd., has resigned effective November 12, 2026, to pursue a new professional opportunity. This is a clear executive departure of a named officer. The company has disclosed interim coverage arrangements (David Vélez and John Walton) and initiated a search for a permanent replacement, confirming the materiality of this C-suite transition at a major digital banking platform.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-23
Item 2.02
Federal Home Loan Bank of San Francisco disclosed third-quarter 2026 operating results via a news release, reporting net income of $64 million, balance sheet data, and key regulatory capital ratios.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-10-23
The 6-K furnishes a press release dated October 22, 2026, announcing that Dynagas LNG Partners LP's Board of Directors has declared a cash distribution of $0.5625 per unit on its Series A Cumulative Redeemable Perpetual Preferred Units, payable November 12, 2026. This is a routine quarterly distribution on preferred units and is material to investors as it affects the total mix of information about the registrant's capital allocation and return to preferred unitholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-23
Item 2.02
The filing discloses preliminary unaudited financial results for Q3 2026 via a press release (Exhibit 99.1), reporting net income of $145 million, total assets of $151.6 billion, and advances outstanding of $72.4 billion. This is a standard quarterly earnings release with condensed financial statements and management commentary, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-23
Item 2.02
The filing discloses preliminary, unaudited quarterly financial results for Q3 2026 via a press release (Exhibit 99.1), reporting net income of $66.4 million, net interest income after provision of $101.7 million, and key balance sheet metrics. This is a classic earnings release disclosure under Item 2.02, with detailed income statement and balance sheet highlights provided in the attached press release.
View raw filing on EDGAR →